Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use.
Cancer Nursing Practice. 19, 4, 12-12. doi: 10.7748/cnp.19.4.12.s9
Alternatively, you can purchase access to this article for the next seven days. Buy now